Back
HOOKIPA Pharma 10K Form
Sell
22
HOOK
HOOKIPA Pharma
Last Price:
4.65
Seasonality Move:
-15.79%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-13 | 10Q | HOOK/HOOKIPA Pharma Quarterly |
| 2020-05-14 | 10Q | HOOK/HOOKIPA Pharma Quarterly |
| 2020-03-19 | 10K | HOOK/HOOKIPA Pharma Annual |
| 2019-11-12 | 10Q | HOOK/HOOKIPA Pharma Quarterly |
| 2019-08-12 | 10Q | HOOK/HOOKIPA Pharma Quarterly |
| 2019-05-20 | 10Q | HOOK/HOOKIPA Pharma Quarterly |
Receive HOOK News And Ratings
See the #1 stock for the next 7 days that we like better than HOOK
HOOK Financial Statistics
Sales & Book Value
| Annual Sales: | $20.13M |
|---|---|
| Cash Flow: | $-14.42M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $8.70 |
| Price / Book: | 0.55 |
Profitability
| EPS (TTM): | -4.32000 |
|---|---|
| Net Income (TTM): | $-48.6M |
| Gross Margin: | -- |
| Return on Equity: | -49.81% |
| Return on Assets: | -30.86% |
HOOKIPA Pharma Earnings Forecast
Key HOOKIPA Pharma Financial Ratios
- The Research & Development expenses have been 429.35% of Revenue.
- The Interest Expense is -0.39% of Operating Income.
- The Net Earning history of HOOK is -405.29% of Total Revenues.
- Per Share Earnings over the last 7 years have been positive in 3 years.
HOOKIPA Pharma Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | HOOK |
| CUSIP: | 43906K |
| Website: | hookipapharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 3.86 |
| Quick Ratio: | 3.58 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
HOOK Technical Analysis vs Fundamental Analysis
Sell
22
HOOKIPA Pharma (HOOK)
is a Sell
Is HOOKIPA Pharma a Buy or a Sell?
-
HOOKIPA Pharma stock is rated a Sell
The current HOOKIPA Pharma [HOOK] share price is $4.78. The Score for HOOK is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.